These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 37955340)

  • 1. Gut microbiota and immunotherapy of renal cell carcinoma.
    Bibbò S; Porcari S; Del Vecchio LE; Severino A; Mullish BH; Ianiro G; Gasbarrini A; Cammarota G
    Hum Vaccin Immunother; 2023 Dec; 19(3):2268982. PubMed ID: 37955340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
    Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
    Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer.
    Ren S; Feng L; Liu H; Mao Y; Yu Z
    Thorac Cancer; 2024 May; 15(14):1149-1163. PubMed ID: 38572783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma.
    Yang JW; Wan S; Li KP; Chen SY; Yang L
    Front Immunol; 2023; 14():1188520. PubMed ID: 37441065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.
    Zhang H; Hong Y; Wu T; Ben E; Li S; Hu L; Xie T
    Front Immunol; 2024; 15():1401967. PubMed ID: 38915399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
    Nguyen CB; Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
    Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
    Front Immunol; 2021; 12():704942. PubMed ID: 34489956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gut microbiome on immunotherapy efficacy in melanoma.
    Bibbò S; Ianiro G; Giambò F; Settanni CR; Cammarota G; Gasbarrini A
    Hum Vaccin Immunother; 2022 May; 18(3):1926759. PubMed ID: 34190675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors.
    Abenavoli L; Montori M; Svegliati Baroni G; Argenziano ME; Giorgi F; Scarlata GGM; Ponziani F; Scarpellini E
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629716
    [No Abstract]   [Full Text] [Related]  

  • 15. The Microbiome in Advanced Melanoma: Where Are We Now?
    Fortman DD; Hurd D; Davar D
    Curr Oncol Rep; 2023 Sep; 25(9):997-1016. PubMed ID: 37269504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome bacterial influencers of host immunity and response to immunotherapy.
    Yousefi Y; Baines KJ; Maleki Vareki S
    Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
    McQuade JL; Ologun GO; Arora R; Wargo JA
    Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microecological regulation in HCC therapy: Gut microbiome enhances ICI treatment.
    Liu X; Li S; Wang L; Ma K
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167230. PubMed ID: 38734322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.